IVVD

Invivyd, Inc.

4.11 USD
-0.06 (-1.44%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Invivyd, Inc. stock is down -16.8% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 February’s closed higher than January. In the last 4 Unusual Options Trades, there were 1 PUT, 3 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jan 16:01 19 Jan, 2024 5.00 PUT 500 532
08 Feb 15:33 20 Sep, 2024 7.50 CALL 636 1
08 Feb 15:38 20 Sep, 2024 7.50 CALL 6779 1
26 Feb 20:52 21 Jun, 2024 5.00 CALL 280 325

About Invivyd, Inc.

Adagio Therapeutics focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease.